Increased malaria parasitaemia among adults living with HIV who have discontinued cotrimoxazole prophylaxis in Kitgum district, Uganda

View/ Open
Date
2020Author
Orishaba, Philip
Kalyango, Joan N.
Byakika-Kibwika, Pauline
Arinaitwe, Emmanuel
Wandera, Bonnie
Katairo, Thomas
Muzeyi, Wani
Tendo Nansikombi, Hildah
Nakato, Alice
Mutabazi, Tobius
Kamya, Moses R.
Dorsey, Grant
Nankabirwa, Joaniter I.
Metadata
Show full item recordAbstract
Although WHO recommends cotrimoxazole (CTX) discontinuation among HIV patients who have undergone immune recovery and are living in areas of low prevalence of malaria, some countries including Uganda recommend CTX discontinuation despite having a high malaria burden. We estimated the prevalence and factors associated with malaria parasitaemia among adults living with HIV attending hospital outpatient clinic before and after discontinuation of CTX prophylaxis.
URI
https://doi. org/10.1371/journal.pone.0240838https://nru.uncst.go.ug/xmlui/handle/123456789/1221
Collections
- Medical and Health Sciences [3684]